510(k) K191167
K191167 is an FDA 510(k) premarket notification submitted by Associates of Cape Cod, Inc. for the device "Fungitell STAT". The FDA issued a decision of Substantially Equivalent on July 17, 2019. The device falls under product code NQZ (Antigen, Invasive Fungal Pathogens), a Class II device regulated under 21 CFR 866.3050. Associates of Cape Cod, Inc. has at least 1 other 510(k) clearance on record.
Clearance Details
- Decision
- SESE (Substantially Equivalent)
- Decision Date
- July 17, 2019
- Date Received
- May 1, 2019
- Clearance Type
- Traditional
- Expedited Review
- No
- Third Party Review
- No
Device Classification
- Device Name
- Antigen, Invasive Fungal Pathogens
- Device Class
- Class II
- Regulation Number
- 866.3050
- Review Panel
- MI
- Submission Type
Invasive fungal pathogen assays are devices that consist of antigens, antisera, or proteases used in serological assays for the presumptive diagnosis of fungal infection in serum or plasma. The assay is indicated for use in patients with symptoms of, or medical conditions predisposing the patient to invasive fungal infection. The device can be used as an aid in the diagnosis of deep seated mycoses and fungemias. A positive result does not indicate which class of fungi may be causing infection. The assays should be used in conjunction with other diagnostic procedures, such as microbiological culture, histological examination of biopsy samples and radiological examination.